Moreover, inhibition of the PI3K/AKT pathway, anti-apoptotic BCL2 protein, and cIAP, as well as activation of FOXO signaling alleviates PAH in the animal models 48. This evidence concerns the gene BCL2 and pulmonary arterial hypertension.